Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.83 USD | -3.98% | +0.42% | -26.26% |
05-08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
05-08 | Transcript : Zevra Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.26% | 211M | |
+7.91% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+20.84% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Maxim Starts Zevra Therapeutics at Buy With $12 Price Target